7 citations
,
June 2022 in “Biology” In this study, researchers observed that male COVID-19 patients with more than 23 CAG repeats in the androgen receptor gene and lower testosterone levels experienced more severe disease outcomes.
4 citations
,
March 2021 in “Le infezioni in medicina” This study found that male COVID-19 patients with androgenic alopecia at a Peruvian hospital were more likely to experience moderate to severe symptoms compared to those without alopecia.
December 2022 in “Pakistan Armed Forces Medical Journal” This study suggests that a high frequency of androgenetic alopecia is associated with increased severity of COVID-19 in hospitalized patients.
5 citations
,
January 2024 in “Journal of Primary Care & Community Health” This study observed that the severity of long COVID symptoms varies among patients and sociodemographic and clinical factors affect the likelihood of experiencing symptoms for more than a year. Understanding these factors may optimize management and improve patient outcomes.
This study observed that post-COVID patients, especially females, commonly experience Telogen Effluvium, with earlier onset and increased trichodynia in those with more severe COVID-19.